(Q37885989)

24 August 2017

1 reference

title

Application and interpretation of free and total drug measurements in the development of biologics (English)

1 reference

24 August 2017

Ago B Ahene

1

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

3

1 reference

24 August 2017

issue

11

1 reference

24 August 2017

page(s)

1287-1295

1 reference

Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

Therapeutic monoclonal antibody concentration monitoring: free or total?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a Generic Immunoglobulin Pharmacokinetic (GRIP) assay

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

HIV entry and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

Pharmacokinetic immunoassay methods in the presence of soluble target

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.104

21 January 2018

Identifiers

DOI

10.4155/BIO.11.104

1 reference

24 August 2017

1 reference